首页|眼科疾病AAV载体基因疗法技术发展新动向

眼科疾病AAV载体基因疗法技术发展新动向

扫码查看
提到"病毒",相信大家对它的第一印象就是"致病"。文章介绍的腺相关病毒(AAV)非但不"致病",还能协助"治病",是基因治疗技术的关键载体。文章对AAV在眼科疾病治疗方面的技术发展动向、应用现状及技术瓶颈进行综述,对比国内外创新主体的专利布局情况,以期对该技术领域的发展热点和国内外发展差距进行初步了解。
New Development Trend of AAV Vector Gene Therapy for Eye Diseases
When it comes to "virus",I believe everyone's first reaction is "disease".The adeno-associated virus(AAV)described in this article is not only not "pathogenic",but also can be used to help "cure"and is a key vector in gene therapy technology.In this paper,the new trends,application status and technical bottlenecks of AAV in ophthalmic diseases are reviewed,and the patent layout of innovative subjects at home and abroad is compared,which can provide a preliminary understanding of the development hotspots and gaps in the field of this technology.

adeno-associated virusAAVeye diseasegene therapy

奚静

展开 >

国家知识产权局专利局专利审查协作北京中心,北京 100160

腺相关病毒 AAV 眼科疾病 基因疗法

2024

工业微生物
全国工业微生物信息中心 上海市工业微生物研究所

工业微生物

影响因子:0.293
ISSN:1001-6678
年,卷(期):2024.54(1)
  • 3